Discovery, Induction, and Screening of Prophages in Clinical Acinetobacter baumannii Isolates

Jessica Trinh1, Vivek K Mutalik2, Catherine M Mageeney1

  • 1Sandia National Laboratories, Livermore, California, USA.

Abstract

Insights

Researchers identified active phages within Acinetobacter baumannii genomes using a computational approach and mitomycin C induction. This study highlights the potential of these prophages as novel therapeutics against antibiotic-resistant bacteria.

Area of Science:

  • Microbiology
  • Genomics
  • Bacteriophage Therapy

Background:

  • Acinetobacter baumannii is a significant cause of hospital-acquired infections.
  • Increasing antibiotic resistance in A. baumannii necessitates alternative treatments like phage therapy.
  • Traditional phage isolation methods are often inefficient and time-consuming.

Purpose of the Study:

  • To develop an efficient method for identifying and isolating Acinetobacter baumannii-infecting phages.
  • To explore the therapeutic potential of bacteriophages against multidrug-resistant A. baumannii.

Main Methods:

  • A computational pipeline was used to identify prophages within A. baumannii genomes.
  • Mitomycin C (MMC) induction was employed to trigger prophage excision from bacterial genomes.
  • Polymerase Chain Reaction (PCR) and sequencing confirmed prophage excision, and electron microscopy visualized virions.

Main Results:

  • Analysis of nearly 900 A. baumannii genomes identified prophages.
  • MMC induction successfully triggered the excision of nine prophages from eight strains.
  • Four prophage-formed virions were observed via transmission electron microscopy, and two phages demonstrated lytic activity.

Conclusions:

  • This study demonstrates a viable strategy for discovering active phages within bacterial genomes.
  • The identified prophages show promise for developing new phage-based therapies against antibiotic-resistant A. baumannii.
  • The diversity of identified prophages underscores their potential as therapeutic agents.